BUYING BUCKYBALLS

Volume 5, #16The ScientistAugust 19, 1991 BUYING BUCKYBALLS Restaurants succeed because people would rather buy the food than prepare and cook it themselves. The situation may be the same with fullerenes--and that's what a handful of companies are banking on. "You can get nice, pure stuff if you make it yourself, but that route is not without problems. It takes about a week to get 250 milligrams of pure material. So the prices are not out of line at all," says Christopher Foote

Written byR. L.
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Restaurants succeed because people would rather buy the food than prepare and cook it themselves. The situation may be the same with fullerenes--and that's what a handful of companies are banking on.

"You can get nice, pure stuff if you make it yourself, but that route is not without problems. It takes about a week to get 250 milligrams of pure material. So the prices are not out of line at all," says Christopher Foote, a chemist at the University of California, Los Angeles.

Price ranges offered by the different companies reflect the newness and rapid pace of fullerene research, with some companies charging different prices for academic and industrial buyers, and offering fullerenes in various degrees of purity. For example, Texas Fullerenes Corp. of Houston--a startup waiting for a license under any patent issued to Richard Smalley, the Rice University professor who deduced the structure of C60--offers impure "C60-rich ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies